Search Results - "Johnson, Isla M."

Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy by Gangat, Naseema, Ilyas, Rimal, Johnson, Isla M, McCullough, Kristen, Al-Kali, Aref, Alkhateeb, Hassan B, Begna, Kebede H, Mangaonkar, Abhishek, Litzow, Mark R, Hogan, William, Shah, Mithun, Patnaik, Mrinal M, Pardanani, Animesh, Tefferi, Ayalew

Get full text

Fatal Powassan virus encephalitis in patients with chronic lymphocytic leukemia by Johnson, Isla M., Scheckel, Caleb, Parikh, Sameer A., Enzler, Mark, Fugate, Jennifer, Call, Timothy G.

Get full text

Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents by Johnson, Isla M., Karrar, Omer, Rana, Masooma, Iftikhar, Moazah, Chen, Sunny, McCullough, Kristen, Saliba, Antoine N., Al‐Kali, Aref, Alkhateeb, Hassan, Begna, Kebede, Litzow, Mark, Hogan, William J., Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Hermann, Joerg, Tefferi, Ayalew, Gangat, Naseema

“…Summary Among 301 newly diagnosed patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent, 23 (7.6%) experienced major cardiac…”
Get full text

Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients by Gangat, Naseema, Karrar, Omer, Iftikhar, Moazah, McCullough, Kristen, Johnson, Isla M., Abdelmagid, Maymona, Abdallah, Mostafa, Al‐Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede H., Mangaonkar, Abhishek, Saliba, Antoine N., Hefazi Torghabeh, Mehrdad, Litzow, Mark R., Hogan, William, Shah, Mithun, Patnaik, Mrinal M., Pardanani, Animesh, Badar, Talha, Murthy, Hemant, Foran, James, Palmer, Jeanne, Sproat, Lisa, Khera, Nandita, Arana Yi, Cecilia, Tefferi, Ayalew

“…Venetoclax + hypomethylating agent (Ven‐HMA) is currently the standard frontline therapy for older/unfit patients with newly diagnosed acute myeloid leukemia…”
Get full text

Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax Combined with Hypomethylating Agents by Johnson, Isla M., Bezerra, Evandro D., Farrukh, Faiqa, McCullough, Kristen, Al-Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede, Litzow, Mark R., Hogan, William J, Shah, Mithun Vinod, Patnaik, Mrinal M., Tefferi, Ayalew, Gangat, Naseema

Get full text

Cardiac Events in Patients with Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents by Johnson, Isla M., Bezerra, Evandro D., Farrukh, Faiqa, McCullough, Kristen, Al-Kali, Aref, Alkhateeb, Hassan B., Begna, Kebede H., Litzow, Mark R., Hogan, William J, Shah, Mithun V., Patnaik, Mrinal M., Tefferi, Ayalew, Gangat, Naseema

“…▪ Background: Venetoclax, a small-molecule inhibitor of B cell leukemia/lymphoma-2, in combination with hypomethylating agents (HMA) has shown improved…”
Get full text